HUMA Historical Earnings image   This HUMA historical earnings page last updated 6/22/2022
HUMA Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20225/13/20220.00B
Q4 20213/29/20220.00B
Q3 202111/12/20210.00B
HUMA Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q1 20225/13/2022-0.190
Q4 20213/29/2022-0.220
Q3 202111/12/2021-0.500
Quotes delayed 20 minutes

Email EnvelopeFree HUMA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Humacyte (HUMA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

HZNP Past Earnings
IART Past Earnings
IBRX Past Earnings
ICAD Past Earnings
ICCC Past Earnings
ICPT Past Earnings
ICUI Past Earnings
ICVX Past Earnings
IDRA Past Earnings
IDXX Past Earnings
What was the record high HUMA historical earnings result?
In terms of earnings or revenue, what is the best HUMA historical earnings result that Humacyte has ever posted, and when?

✔️Accepted answer: Within our data set, the highest HUMA historical earnings result was set in Q1 2022, when Humacyte posted results of -0.190/share. The most successful revenue quarter within our data set was Q3 2021 when Humacyte reported revenue of 0.00B.

What was the lowest Humacyte historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest HUMA has reported, and when?

✔️Accepted answer: Within our data set, the lowest HUMA historical earnings result was set in Q3 2021, when Humacyte posted results of -0.500/share. The smallest revenue quarter within our data set was Q4 2021 when Humacyte reported revenue of 0.00B.

On this page we presented the HUMA historical earnings date information for Humacyte. Reviewing that HUMA Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2022, when HUMA posted gaap of -0.190/share. Meanwhile the lowest HUMA historical earnings result was in Q3 2021, when HUMA posted gaap of -0.500/share. Moving to Humacytes historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2021 when HUMA reported 0.00B in revenue, while the smallest revenue quarter was Q4 2021 when HUMA reported 0.00B in revenue.

For self directed investors doing their due diligence on HUMA or any other given stock, their research can benefit from looking into all of the Humacyte historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Humacyte historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for HUMA. Thanks for visiting, and the next time you need to research HUMA historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Top Ten Hedge Funds Holding STRN, WDC Insider Buying, Funds Holding PEAR.

 

HUMA Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.